In the pharmaceutical context, the term “biologics” generally refers to protein-based medicines that are made in living cells, such as insulin and human growth hormone.
Register now for your free, tailored, daily legal newsfeed service.
Questions? Please contact [email protected]
RegisterVariations on a theme: five proposed abbreviated approval pathways for biogenerics
To view this article you need a PDF viewer such as Adobe Reader.
USA
May 5 2009
Popular articles from this firm
If you would like to learn how Lexology can drive your content marketing strategy forward, please email [email protected].
